SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
Led by a team of Cornell faculty, the Northeast Regional Center for Excellence in Vector-Borne Diseases received a five-year, $8.7 million grant from the Centers for Disease Control and Prevention in ...
Soon, the public health community will be better equipped to respond to outbreaks of diseases spread by mosquitoes and other arthropod vectors, thanks to a contract awarded to the Entomological ...